Travere Therapeutics, Inc. (TVTX)
50.65
-0.91
(-1.76%)
USD |
NASDAQ |
Nov 13, 16:00
50.70
+0.05
(+0.10%)
After-Hours: 07:26
Travere Therapeutics Price to Book Value : 214.57 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 214.57 |
| November 12, 2026 | 218.43 |
| November 11, 2026 | 220.46 |
| November 10, 2026 | 220.25 |
| November 09, 2026 | 218.73 |
| November 06, 2026 | 210.13 |
| November 05, 2026 | 207.03 |
| November 04, 2026 | 222.07 |
| November 03, 2026 | 209.32 |
| November 02, 2026 | 208.68 |
| October 30, 2026 | 213.47 |
| October 29, 2026 | 214.23 |
| October 28, 2026 | 215.40 |
| October 27, 2026 | 215.55 |
| October 26, 2026 | 211.69 |
| October 23, 2026 | 212.16 |
| October 22, 2026 | 222.11 |
| October 21, 2026 | 222.75 |
| October 20, 2026 | 221.56 |
| October 19, 2026 | 213.90 |
| October 16, 2026 | 210.13 |
| October 15, 2026 | 223.64 |
| October 14, 2026 | 225.67 |
| October 13, 2026 | 219.45 |
| October 12, 2026 | 220.38 |
| Date | Value |
|---|---|
| October 09, 2026 | 220.82 |
| October 08, 2026 | 220.46 |
| October 07, 2026 | 226.39 |
| October 06, 2026 | 237.15 |
| October 05, 2026 | 244.31 |
| October 02, 2026 | 241.18 |
| October 01, 2026 | 240.84 |
| September 30, 2026 | 249.44 |
| September 29, 2026 | 230.38 |
| September 28, 2026 | 236.45 |
| September 25, 2026 | 228.27 |
| September 24, 2026 | 232.80 |
| September 23, 2026 | 229.77 |
| September 22, 2026 | 231.50 |
| September 21, 2026 | 241.41 |
| September 18, 2026 | 241.02 |
| September 17, 2026 | 248.63 |
| September 16, 2026 | 243.79 |
| September 15, 2026 | 240.06 |
| September 14, 2026 | 252.66 |
| September 11, 2026 | 254.12 |
| September 10, 2026 | 259.26 |
| September 09, 2026 | 254.31 |
| September 08, 2026 | 253.73 |
| September 04, 2026 | 250.70 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Vertex Pharmaceuticals, Inc. | 6.531 |
| TG Therapeutics, Inc. | 17.04 |
| Viridian Therapeutics, Inc. | 7.261 |
| Arrowhead Pharmaceuticals, Inc. | 134.18 |
| BioMarin Pharmaceutical, Inc. | 1.772 |
Price to Book Value Related Metrics
| PS Ratio | 7.202 |
| PEG Ratio | -0.5765 |
| Price to Free Cash Flow | 54.69 |
| Price | 50.65 |
| Earnings Yield | -3.28% |
| Market Cap | 4.846B |
| PEGY Ratio | -0.5765 |